Citi Pharma Limited (PSX:CPHL)
Pakistan
· Delayed Price · Currency is PKR 92.50
-1.71 (-1.82%)
At close: Apr 23, 2025
Citi Pharma Market Cap
Citi Pharma has a market cap or net worth of 20.10 billion as of April 24, 2025. Its market cap has increased by 279.02% in one year.
Market Cap
20.10B
Enterprise Value
20.72B
Revenue
13.19B
Ranking
n/a
PE Ratio
24.45
Stock Price
92.50
Market Cap Chart
Since July 9, 2021, Citi Pharma's market cap has increased from 7.14B to 20.10B, an increase of 181.30%. That is a compound annual growth rate of 31.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 21.13B | 35.81% |
| Dec 31, 2024 | 15.56B | 186.90% |
| Dec 29, 2023 | 5.42B | -1.70% |
| Dec 30, 2022 | 5.52B | -32.47% |
| Dec 31, 2021 | 8.17B | 14.35% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GlaxoSmithKline Pakistan | 144.99B |
| Abbott Laboratories (Pakistan) | 103.67B |
| AGP Limited | 58.68B |
| Highnoon Laboratories | 49.27B |
| The Searle Company | 47.77B |
| Shifa International Hospitals | 26.98B |
| Ferozsons Laboratories | 13.11B |
| Otsuka Pakistan | 2.03B |